Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
Condition(s):COVID-19Last Updated:March 15, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):COVID-19Last Updated:March 15, 2021Recruiting
Condition(s):Thymic Malignancies; Pleural MetastasesLast Updated:December 7, 2023Recruiting
Condition(s):Radiation Dermatitis; Skin Microbiome; Breast Cancer; Reconstructive SurgeryLast Updated:September 2, 2021Recruiting
Condition(s):Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to RadiationLast Updated:May 25, 2023Recruiting
Condition(s):Radiation OncologyLast Updated:January 12, 2024Not yet recruiting
Condition(s):Breast Cancer; Myocardial Fibrosis; Radiation-Induced FibrosisLast Updated:January 12, 2024Recruiting
Condition(s):Cancer; Metastatic CancerLast Updated:March 15, 2024Not yet recruiting
Condition(s):Early Breast Cancer; Radiation Associated Cardiac FailureLast Updated:October 8, 2020Recruiting
Condition(s):Lung Cancer; Radiation Therapy ComplicationLast Updated:November 26, 2021Recruiting
Condition(s):Palliative Radiotherapy; Radiotherapy, Intensity-ModulatedLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.